Volatile Week, but Green? Click to watch the new Podcast.

Catalyst Pharmaceuticals Stock Forecast

NASDAQ:CPRX BUY SELL

$7.40 (4.82%)

Volume: 1.535M

Closed: Jul 05, 2022

Hollow Logo Score: 0.000

Catalyst Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:CPRX
$7.40 (4.82%)

Volume: 1.535M

Closed: Jul 05, 2022

Score Hollow Logo 0.000

Catalyst Pharmaceuticals Stock Price (Quote) NASDAQ:CPRX

$7.40 ( 4.82% ) Tuesday, 5th Jul 2022

Range Low Price High Price Comment
30 days $6.15 $7.42 Tuesday, 5th Jul 2022 CPRX stock ended at $7.40. This is 4.82% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 7.07% from a day low at $6.93 to a day high of $7.42.
90 days $6.15 $8.64
52 weeks $4.81 $8.65

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2022-07-05 $6.97 $7.42 $6.93 $7.40 1 535 318
2022-07-01 $6.99 $7.10 $6.87 $7.06 1 222 384
2022-06-30 $6.85 $7.11 $6.85 $7.01 1 256 997
2022-06-29 $6.91 $6.98 $6.81 $6.95 751 825
2022-06-28 $7.19 $7.23 $6.82 $6.88 984 915
2022-06-27 $6.68 $7.13 $6.63 $7.10 888 920
2022-06-24 $6.74 $6.79 $6.43 $6.64 3 760 773
2022-06-23 $6.59 $6.72 $6.47 $6.69 1 285 507
2022-06-22 $6.43 $6.72 $6.38 $6.57 678 439
2022-06-21 $6.55 $6.76 $6.54 $6.56 1 056 023
2022-06-17 $6.38 $6.68 $6.29 $6.45 1 802 994
2022-06-16 $6.36 $6.43 $6.25 $6.38 1 013 310
2022-06-15 $6.42 $6.59 $6.30 $6.51 1 458 775
2022-06-14 $6.25 $6.39 $6.20 $6.36 1 106 529
2022-06-13 $6.50 $6.60 $6.15 $6.23 1 226 335
2022-06-10 $6.52 $6.80 $6.52 $6.68 1 230 451
2022-06-09 $6.93 $7.03 $6.63 $6.65 731 518
2022-06-08 $7.10 $7.21 $6.95 $6.96 881 863
2022-06-07 $7.00 $7.22 $6.95 $7.17 573 416
2022-06-06 $7.41 $7.41 $6.92 $7.02 1 036 354
2022-06-03 $7.08 $7.37 $7.08 $7.36 799 075
2022-06-02 $6.99 $7.16 $6.93 $7.09 547 746
2022-06-01 $7.25 $7.30 $6.92 $7.03 1 161 502
2022-05-31 $7.31 $7.42 $7.10 $7.20 976 054
2022-05-27 $7.07 $7.38 $6.94 $7.33 965 591
2022-05-26 $6.89 $7.07 $6.82 $7.02 768 943
2022-05-25 $6.84 $6.94 $6.62 $6.88 998 434
2022-05-24 $6.81 $6.96 $6.73 $6.87 841 734
2022-05-23 $7.16 $7.22 $6.89 $6.92 1 016 148
2022-05-20 $6.94 $7.17 $6.78 $7.06 1 040 579
2022-05-19 $6.75 $7.01 $6.72 $6.92 1 057 363
2022-05-18 $7.21 $7.21 $6.73 $6.82 1 073 509
2022-05-17 $7.12 $7.22 $6.96 $7.17 1 830 437
2022-05-16 $6.86 $7.10 $6.69 $7.00 1 146 764
2022-05-13 $6.74 $6.94 $6.71 $6.91 1 543 187
2022-05-12 $6.51 $6.76 $6.43 $6.65 1 976 890
2022-05-11 $6.84 $6.87 $6.30 $6.51 1 849 155
2022-05-10 $6.64 $7.02 $6.50 $6.93 2 710 241
2022-05-09 $7.10 $7.26 $6.49 $6.54 2 996 751
2022-05-06 $7.42 $7.51 $7.17 $7.22 1 083 499
2022-05-05 $7.75 $7.81 $7.38 $7.53 1 285 290
2022-05-04 $7.79 $7.89 $7.40 $7.82 1 273 863
2022-05-03 $7.82 $7.83 $7.63 $7.73 752 978
2022-05-02 $7.62 $7.83 $7.57 $7.81 1 299 173
2022-04-29 $7.79 $7.98 $7.54 $7.62 1 081 827
2022-04-28 $7.90 $8.03 $7.38 $7.82 1 087 892
2022-04-27 $7.84 $8.03 $7.75 $7.79 984 770
2022-04-26 $8.19 $8.23 $7.83 $7.85 1 301 348
2022-04-25 $7.96 $8.25 $7.91 $8.25 793 851
2022-04-22 $8.22 $8.28 $8.03 $8.05 867 600

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 26 218 stocks, only a few dozen will trigger such a signal!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which completed Phase III clinical trial for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as w... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT